ArticleWorld journal of urology2023

Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis.

Takafumi Yanagisawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.